Elekta Ab Class B · OMXSTO:EKTA_B
Elekta Ab Class B — Investor Presentation (2010)
14 slides from Elekta Ab Class B's investor presentation, 2010
Slide 1: Region North America
Region North America Jay Hoey Executive Vice President Region North America
Slide 2: Market Fundamentals
Market Fundamentals Human Care Makes ze° the Future Possible *) E L E KTA
Slide 3: Patient demand continues to grow
Patient demand continues to grow Change in patient volumes of the past 12 months n= 177 Steady volume increase Decreased ≥ 5% Volume increases due to: Decreased 9% • Aging baby boomers 0-5% Increased 10% 28% ≥ 5% • Non-elective nature of cancer treatment Stayed 26% • Improvements in survival, the sa
Slide 4: Uninsured population continues to grow
Uninsured population continues to grow Programs reporting change in uninsured patients over the past 12 months n= 137 Effect of increase in unemployment 2008-2009 4.3 M No change 24% 27% Increase 3.9 M 0-5% Decrease 0-5% 10% + 10% 29% Increase in Increase in Increase in Decrease National medicaid an
Slide 5: Provider competition continues to grow
Provider competition continues to grow • 90+ cancer centers Hospital-based Competition • Medical and radiation oncology, diagnostics and Significantly decreased 2% clinical research Decreased 6% Significantly increased • 49 centers in 8 states No change 14% 32% • Full complement of radiation therapy
Slide 6: Market position: Installed base share
Market position: Installed base share Oncology Hardware Oncology Software OIS 2% 2% 2% 1% 4% 11% 10% 12% 54% 31% 71% Oncology Software TPS Stereotactic Radiosurgery 5% Elekta 22% 15% Varian Siemens 32% 41% Tomo 35% 28% Accuray 22% Philips Other
Slide 7: Market position - Market share (FY09-10)
Market position - Market share (FY09-10) Oncology Hardware Stereotactic Radiosurgery 4% 2% 5% 6% 4% 22% 32% 41% 62% 22% ** Oncology Software Elekta 7% Varian Siemens 23% 35%* Tomo Accuray 35% Philips Other * Includes Siemens OEM ** Includes BrainLab/Novalis Tx
Slide 8: Market Trends: Healthcare Economics & Policy
Market Trends: Healthcare Economics & Policy
Slide 9: Health insurance reform in the US
Health insurance reform in the US • Congressional budget estimates – First decade cost ~ USD 950 B; Net Deficit Reduction ~ USD143 B • Health insurance coverage expansion to 32 million uninsured • Funded through USD 500 B in Medicare cuts and USD 583 B in new taxes, fees and cost savings (first deca
Slide 10: Reimbursement
Reimbursement Healthcare insurance • Radiation Therapy and Radiosurgery treatments coverage for are covered by most all public and private payors the United States* • Cancer incidence increases with age; majority of RT departments payor mix is above 50% Medicare Un- • Public insurance (e.g. Medicare
Slide 11: Elekta software positioned to benefit
Elekta software positioned to benefit by government-sponsored Hospital IT spending Situation • $19B allocated by the American Recovery and Reinvestment Act (ARRA) • Incentives for physicians who use a certified EMR in a “Meaningful way” • Medicare incentives-up to $44K over 5 years • Medicaid incent
Slide 12: Spotlight on safety
Spotlight on safety • Series of New York Times articles in Jan and Feb turns national attention to the topic of safety of radiation therapy • Elekta immediately establishes internal safety committee in response – Focus on all aspects of safety: internal and external education, product design and man
Slide 13: Market Outlook North America
Market Outlook North America
Slide 14: Market outlook, North America
Market outlook, North America • Oncology remains a technology-driven industry • Slow market recovery • Health Insurance Reform results in some opportunities, some risk • Provider competition and Supplier competition is high in a still uncertain market • Elekta is in a good position for providing sol